Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-20

Clinical Trial Update: Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) [Phase 4]

View source ↗

Summary

Phase 4 VERITAS trial comparing Varithena with endothermal ablation for great saphenous vein varicose veins was terminated. Results have been posted (as of 2026…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varithena (polidocanol injectable foam)

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Varicose Veins | Phase 4 | Status: TERMINATED | Results posted: 2026-03-20